Conclusion In conclusion, the preclinical and clinical studies demonstrated that GLP-1RAs and SGLT-2is act directly or indirectly on their receptors by crossing the BBB
We expect to dose the first patient and report initial data in the second half of 2026. Later this year, Fractyl expects to expand the study to additional sites in Australia, where the company has already submitted a clinical trial application and is currently awaiting a response from regulators
In cell and animal studies, it and its metabolites (e.g., berberrubine, palmatine) boost secretion of GLP-1, increase GLP-1 receptor expression, and limit GLP-1 breakdown
Read it here: #Pharma #Pharmaceutical #LifeSciences #Healthcare #GLP1 #Biopharma To view or add a comment, sign in More Relevant Posts The Sievers range of #Analytical instruments for #PureWater resonates so well with my R&D chemistry background
Once you understand who your consumer is and what drives their decisions, the next step is figuring out how to reach them and how your tech fits into the story they want to tell about themselves
The concentrations inside the pens vary to achieve different doses in the same volume
